Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cellerant Therapeutics logo — Pioneering universal cell therapy to combat bacterial and fu...

Cellerant Therapeutics

Pioneering universal cell therapy to combat bacterial and fungal infections during neutropenia.

Founded 2003 United States San Carlos, United States 4 employees Grant Total: $109.77M Biotechnology, Health and Wellness

General Information

Company Name Cellerant Therapeutics
Founded Year 2003
Location United States San Carlos, United States +1
Founders / Decision Makers
Team member
Employees 4
Industries Biotechnology, Health and Wellness
Funding Stage Grant
Social

Get notified when Cellerant Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cellerant Therapeutics

Cellerant Therapeutics is a biotechnology startup founded in 2003 and headquartered in San Carlos, California. The company is focused on developing novel cell- and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. One of their key products, Romyelocel-L, is a universal cell therapy designed to combat bacterial and fungal infections during neutropenia without the need for HLA matching. In September 2016, Cellerant Therapeutics secured a $1.50M grant investment to support its pioneering work in this field. With a strong emphasis on addressing critical medical needs, particularly in the context of weakened immune systems, Cellerant's innovative approach holds significant promise for the future of combating infections in vulnerable patient populations.

Taxonomy: Cell Therapy, Immunotherapy, Hematologic Malignancies, Blood Disorders, Clinical-Stage, Antibody-Based Therapies, Neutropenia, Bacterial Infections, Fungal Infections, HLA Matching, San Carlos, California, Romyelocel-L, Innovative Therapies

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• - 26 Sep 2016
Debt Financing •••••• - 13 Apr 2016
Grant •••••• - 11 Sep 2014
Debt Financing •••••• - 22 Jan 2014
Venture Round •••••• 2
Investor
•••• •••• 		28 Sep 2012

View All 12 Funding Rounds

Cellerant Therapeutics Alternatives & Competitors

Cellerant Therapeutics vs
Caribou Biosciences
Caribou Biosciences United States

Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating hu...

IPO
128 employees
Biotechnology, Health Care
Cellerant Therapeutics vs
Alphageneron Pharmaceuticals
Alphageneron Pharmaceuticals United States

Our seasoned team of biopharmaceutical executives, scientists and clinicians, are an integral elemen...

3 employees
Biotechnology, Health and Wellness
Cellerant Therapeutics vs
ProfoundBio
ProfoundBio United States

An oncology biotherapeutics company

Series B
8 employees
Biotechnology, Health and Wellness

FAQ About Cellerant Therapeutics

Pioneering universal cell therapy to combat bacterial and fungal infections during neutropenia.
Cellerant Therapeutics was founded in 2003.
Cellerant Therapeutics is headquartered in San Carlos, United States.
Cellerant Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
Cellerant Therapeutics has approximately 4 employees.
Cellerant Therapeutics has completed 12 funding rounds, raising a total of $109.77M. The latest funding stage is Grant.
Top alternatives and competitors to Cellerant Therapeutics include Caribou Biosciences, Alphageneron Pharmaceuticals, ProfoundBio, CARsgen Therapeutics, iCell Gene Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellerant Therapeutics and Caribou Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cellerant Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy